Survival and Lates Effects of JPLT (Japanese Study Group for Rediatric Liver Tumor)-2 Risk-Stratified Study for Hepatoblastoma

被引：0
|
作者：
Hiyama, E. [1 ]
Hishiki, T. [2 ]
Ida, K. [2 ]
Watanabe, K. [2 ]
Tanaka, Y. [2 ]
Aoki, Y. [2 ]
Iehara, T. [2 ]
Kazama, T. [2 ]
Kihira, K. [2 ]
Taguchi, T. [2 ]
Fujimura, J. [2 ]
Hoshino, K. [2 ]
Honda, S. [2 ]
Matsumoto, K. [2 ]
Mori, M. [2 ]
Yano, M. [2 ]
机构：
[1] Hiroshima Univ Hosp, Peditr Surg, Hiroshima, Japan
[2] Japanese Children Canc Grp, Liver Tumor Comm, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-126
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [41] Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study
    Kowada, Akiko
    BMJ OPEN, 2024, 14 (11):
  • [42] Risk-stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10-year follow-up
    He, Hua
    Wu, Yanhua
    Jia, Zhifang
    Xu, Hongqin
    Pan, Yuchen
    Cao, Donghui
    Zhang, Yangyu
    Tao, Xuerong
    Zhao, Tianye
    Lv, Haiyong
    Yi, Jiaxin
    Wang, Yuehui
    Gao, Yanhang
    Kou, Changgui
    Niu, Junqi
    Jiang, Jing
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (11) : 859 - 869
  • [43] SURVIVAL OF PATIENTS WITH STAGE B2 COLON-CARCINOMA - THE GASTROINTESTINAL TUMOR STUDY-GROUP EXPERIENCE
    NAUTA, R
    STABLEIN, DM
    HOLYOKE, D
    ARCHIVES OF SURGERY, 1989, 124 (02) : 180 - 182
  • [44] Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: A biodistribution and survival study
    Vali, Mustafa
    Vossen, Josephina A.
    Buijs, Manon
    Engles, James M.
    Liapi, Eleni
    Ventura, Veronica Prieto
    Khwaja, Afsheen
    Acha-Ngwodo, Obele
    Shanmugasundaram, Ganapathy
    Syed, Labiq
    Wahl, Richard L.
    Geschwind, Jean-Francois H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (01): : 32 - 37
  • [45] Effect of very small tumor size on recurrence-free survival and breast cancer-specific mortality stratified by guideline adherence: An analysis of the BRENDA Study Group
    Woeckel, Achim
    Schwentner, Lukas
    Wischnewsky, Manfred
    Kreienberg, Ralf
    Wolters, Regine
    Grp, B. R. E. N. D. A. Study
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group
    Joko, Kouji
    Goto, Tohru
    Watanabe, Hiroshi
    Mitsuda, Akari
    Uchida, Yasushi
    Hasebe, Chitomi
    Tsuruta, Shotaro
    Kimura, Hiroyuki
    Koike, Takero
    Akamatsu, Takuji
    Mashiba, Toshie
    Ochi, Hironori
    Nakamura, Yoshiko
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2016, 46 (04) : 251 - 258
  • [47] COMPLETE RESECTION BEFORE DEVELOPMENT OF DRUG-RESISTANCE IS ESSENTIAL FOR SURVIVAL FROM ADVANCED HEPATOBLASTOMA - A REPORT FROM THE GERMAN COOPERATIVE PEDIATRIC LIVER-TUMOR STUDY HB-89
    VONSCHWEINITZ, D
    HECKER, H
    HARMS, D
    BODE, U
    WEINEL, P
    BURGER, D
    ERTTMANN, R
    MILDENBERGER, H
    JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (06) : 845 - 852
  • [48] Real-world efficacy and safety of sofosbuvir plus ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
    Akahane, Takehiro
    Kurosaki, Masayuki
    Itakura, Jun
    Tsuji, Keiji
    Joko, Kouji
    Kimura, Hiroyuki
    Nasu, Akihiro
    Ogawa, Chikara
    Kojima, Yuji
    Hasebe, Chitomi
    Wada, Shuichi
    Uchida, Yasushi
    Sohda, Tetsuro
    Suzuki, Hideyuki
    Yoshida, Hideo
    Kusakabe, Atsunori
    Tamada, Takashi
    Kobashi, Haruhiko
    Mitsuda, Akeri
    Kondo, Masahiko
    Shigeno, Masaya
    Ide, Yasushi
    Morita, Atsuhiro
    Kitamura, Tadashi
    Abe, Takehiko
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2019, 49 (03) : 264 - 270
  • [49] The crossover of the bevacizumab and panitumumab survival curves in the PARADIGM study: A clue to time-related effects of bevacizumab on the risk of tumor progression.
    Aderka, Dan
    Muro, Kei
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 159 - 159
  • [50] Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
    D. Gareth Evans
    Lorna McWilliams
    Susan Astley
    Adam R. Brentnall
    Jack Cuzick
    Richard Dobrashian
    Stephen W. Duffy
    Louise S. Gorman
    Elaine F. Harkness
    Fiona Harrison
    Michelle Harvie
    Andrew Jerrison
    Matthew Machin
    Anthony J. Maxwell
    Sacha J. Howell
    Stuart J. Wright
    Katherine Payne
    Nadeem Qureshi
    Helen Ruane
    Jake Southworth
    Lynne Fox
    Sarah Bowers
    Gillian Hutchinson
    Emma Thorpe
    Fiona Ulph
    Victoria Woof
    Anthony Howell
    David P. French
    British Journal of Cancer, 2023, 128 : 2063 - 2071
12345